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the incidence rate calculations. Case-fatality rates are the
percentage of HDTP cases who died.
Results: Overall, the observed rate of HDTP in Brazil has
shown a downward trend averaging 4.5 per 1000 residents
in 2003, and 3.9 in 2007. Children <1 year old had the high-
est reduction in rates of HDTP, from 47 per 1000 in 2003 to
36.4 in 2006. Brazilians 80+ years old had the next highest
incidence rates, averaging about 23 to 27 HDTPs per 1000
residents during the study period. CFRs related to HDTP have
increased steadily over time, averaging 2.9% in 2003, and 4%
in 2007. With the exception of the <1 year old age-group,
CFRs increased with age, and in the 80+ age group averaged
between 16% and 18%. In age groups under 5 years, CFRs
have declined slightly beween 2003 and 2007. In all other
age-groups, particularly the ones 30 years and older, CFRs
have generally risen.
Conclusion: As expected, the highest rates of HDTP were
observed in the extremes of age, very young and old. While
a slight reduction has been observed in HDTP rates, CFRs
have progressively risen during this same period particularly
for adults aged 80+. Pneumonia remains an important health
problem in Brazil.
doi:10.1016/j.ijid.2010.02.1937
51.006
Meningococcal meningitis epidemic in Arua district North
West of Uganda
M. Busuulwa
Medical Epidemiologist, Kampala, US, Uganda
Background: Meningitis due to Neisseria meningitidis has
an epidemic potential and a high case fatality rate. On
3rd September 2008, a meningitis epidemic was reported
in Arua district health ofﬁce, in north western Uganda. The
objective of the investigation was to conﬁrm the menin-
gitis epidemic, identify the causative agent, risk factors
and assess the district response capacity to handle the epi-
demic.
Methods: Community based cross-sectional study. We
purposively selected cases, their families, District health
team & local leaders for interview. Cerebral spinal ﬂuid sam-
ples were drawn from cases and sent to Central Public Health
Laboratory of Ministry of Health to isolate the causative
agent. Frequencies and distributions of cases with respect
to age groups and affected communities with EPIINFO 2006
were done.
Results: A total of 44 cases were detected and 10 deaths
occurred to meningitis. The Case Fatality Rate was 22.7%:
highest CFR (46.2%) occurred in those above 30years.Age
range was 3months to 65years. The causative agent for this
meningitis epidemic was identiﬁed to be Neisseria meningi-
tides type A with latex rapid test. 70.5% of the cases were
Years 2003 2004 20
No of cases 16 or10.89% 36 or 24.5% 61<30 years and the male to female ratio was 1:2. Charac-
teristically, it was discovered that the epidemic occurred
in the area which had missed vaccination against menin-
s
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itis in the previous outbreak of meningitis. Sleeping in
oorly ventilated huts and overcrowding: 3-5 huts with 7-
0 people/family cluster were risk factors to this mening-
tis.
Conclusion: Highest case fatality rate occurred amongst
ersons who are over 30 yrs old. Overcrowding, staying in
oorly ventilated huts and lack of previous vaccination were
hought to be predisposing factors to this meningitis epi-
emic.
oi:10.1016/j.ijid.2010.02.1938
1.007
he study of epidemiological data of the mumps and the
ffect of MMR vaccine in the Albanian children
. Hoxha1,∗, A. Simaku2, E. Kallfa-Foto3, G. Lito3, R.
etrela3, E. Thartori 1
University Hospital Center ‘‘Mother Theresa’’, Tirana,
lbania
Institute Public Health, Tirana, Albania
University Hospital Center Mother Theresa Tirana, Alba-
ia, Tirana, Albania
Background: Up to March 2005 in our country mumps was
ndemic diseases with every year epidemic and the chil-
ren were unvaccinated for these diseases. From March to
eptember 2005 was made a massive MMRII vaccination for
he children under 7 years and from this year this vaccine
as included in our routine national program vaccination.
he incidence of this diseases in years 2003 was 72.9/100000
abitants and in 2007,2008 were respecti vely 26.9 and
.6/100000
The aim of the study: was to show the epidemiological
ata of the mumps and his complications in Albanian chil-
ren and to show the effect of the MMRII vaccine in the
ecrease of the incidence of this diseases in Albania.
Methods: This is a retrospective study .In this study were
nrolled 147 children admitted in our hospital from January
003 to December 2008.The children were the age from 18
onths to 14 years old. For each children were studied the
ex, the age, the season, origin, complications, length of
he hospitalization and the status of the vaccination. All the
atients admitted in the hospital before March 2005 were
nvaccinated.
Results: The average age was 6.3, 96 cases or 65.3%
ere 5-14 years old followed by 1-4years old with 47 cases
r 31.9%,predominantly male patients with 112 cases or
6.19%, 105 cases or 71,43% were admitted in the spring
nd summer seasons, there is not any difference for origin.
e saw these complications: neurological manifestations in
1 cases or 41.5%, pancreatitis 24 cases or 16.3%, orchitis 18
ases or 12.2% manly in the patients up 12 years old, tonsil-
itis and maxillitis 28 cases19.1%.The spread of the patients
y years was shown in the following table:
2006 2007 2008
1.5% 23 or 15.6% 9 or 6.12% 2 or 1.36%Conclusion: The majority of the cases was happen in the
ummer and spring, the male suffer more often from this
iseases and the neurological manifestation were seen more
ften as othermanifestations. In the last 2 years, the vaccine
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gainst mumps have reduce very much the incidence of this
iseases in our country.
oi:10.1016/j.ijid.2010.02.1939
1.008
ertussis in Brazil: An overview from 1988 to 2009
. Leite ∗, L.C.V. Melo, T.M.I. Vaz, K. Irino
Instituto Adolfo Lutz, São Paulo, Sao Paulo, Brazil
Background: The introduction of pertussis vaccination in
he past decades reduced substantially the number of cases;
owever, despite the high vaccination coverage rates, per-
ussis is still a major threat to public health all over the
orld including Brazil. In this study we present an overview
f pertussis in Brazil in the last two decades.
Methods: Between 1988 and 2009, the National Refer-
nce Laboratory for Pertussis, Instituto Adolfo Lutz, São
aulo, Brazil, received a total of 985 presumptively iden-
iﬁed Bordetella spp strains, isolated from sporadic cases
nd/or some pertussis outbreaks. The strains were for-
arded by the Regional Laboratories in São Paulo State and
y the Central Public Health Laboratories throughout the
ountry. Identiﬁcation of the species was done by standard
ethods. Detection of O1 antigen, and the serotyping were
one by slide agglutination test using O1, and Fim 2 and Fim
antibodies, respectively. Molecular characterization was
one by Pulsed Field Gel Electrophoresis (PFGE).
Results: All the 985 strains were conﬁrmed as Bordetella
ertussis and the most of them belonged to the serotype
,3. Strains from southeastern states accounted for 67%
660/985), most of them from São Paulo State (646/985;
5.6%). The remaining 325 strains were from south region
147/985, 15%), northeastern states (87/985, 8.8%), north
egion (48/985, 5%) and central area (43/985, 4.4%). The
reat majority (81.1%, 799/985) was from children under
welve years of age, and among them 84.4% (675/799)
as from infants aged less than six months. Strains from
dolescents and adults accounted for 3.2% (32/985) and
% (78/985), respectively. The age group was unknown in
pproximately 7.7%. Strains belonging to several PFGE pat-
erns were identiﬁed and some were prevalent.
Conclusion: Different B. pertussis clones circulate all
ver the country. These data do not cover all the country,
nd may represent only a fraction of the actual number of
ertussis cases due to the underreporting, despite pertus-
is is, in Brazil, a reportable disease since 2001. Data on age
istribution of pertussis cases may contribute to develop the
olicy of booster doses of vaccine in adolescents and adults.
oi:10.1016/j.ijid.2010.02.1940
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erogroup B epidemiology in the southern cone of South
merica. A literature review
. Da Silva ∗, M.H. KyawNovartis Vaccines and Diagnostics, Cambridge, MA, USA
Background: The epidemiology of meningococcal disease
iffers greatly by country and time period. Only passive
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urveillance systems for meningococcal disease exist in
ountries in South America. Thus, little is known about
he pattern of serogroup distribution by country in this
egion. Existing data showed that serogroup B is prevalent
orldwide, with various strains and clones causing endemic,
poradic and epidemic disease. Several of these clones are
ery virulent. Understanding the local and national seroepi-
emiology of group B meningococcal disease is critical for
accine formulations and vaccine policies.
Methods: We examined the current disease burden
aused by serogroup B in the southern cone of South Amer-
ca, comprised of Brazil, Uruguay, Paraguay, Chile, and
rgentina. Clinical data were retrieved following systematic
eview of the literature by country. The 2008 SIREVA report
n invasive disease was also consulted.
Results: Until the late twentieth century, countries in
he southern cone had similar disease epidemiology to Latin
merica as a whole. However, in recent years, this has
hanged. In Brazil, signiﬁcant differences in epidemiology
an be identiﬁed between areas close to other southern cone
ountries and areas bordering Andean or Caribbean coun-
ries. Fluctuations in the proportion of serogroup B versus
erogroup C disease have been observed in southern cone
ountries, yet serogroup B consistently accounted for a sig-
iﬁcant disease burden throughout the early 21st century.
or example, 100% of serotypable meningococcal disease
eported in Chile between 1990 and 2003 was attributed
o serogroup B, as was 40% to 65% of disease in Brazil. In
rgentina, serogroup B consistently accounts for about 60%
f invasive meningococcal disease. Even with the emergence
f disease caused by Serogroups Y and W-135 in Brazil and
rgentina since 2000, serogroup B has remained the cause
f a consistent and ongoing public health problem.
Conclusion: Invasive disease caused by meningococcal
erogroup B remains an important public health issue in the
outhern cone countries. An effective vaccine against group
meningococcal is needed to reduce the burden of disease
n South America.
oi:10.1016/j.ijid.2010.02.1941
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tatus of bloodborne pathogen education for injection
rug users in Indiana hospital emergency departments
. Wenger
Indiana State Department of Health, Indianapolis, IN, USA
Background: The problem of the study was to determine
he status of bloodborne pathogen education for injec-
ion drug users in Indiana hospital emergency departments.
orty-six instruments were returned for a response rate of
3.8%.
Methods: The study was designed to answer the follow-
ng research questions: (a) Do Indiana hospital emergency
epartments have written policies on bloodborne pathogen
ducation for injection drug users? (b) To what extent
o Indiana hospital emergency departments provide blood-
orne pathogen education for injection drug users? and (c)
hat are the major barriers for Indiana hospital emergency
epartments in providing bloodborne pathogen education
or injection drug users? A valid instrument was developed
